نتایج جستجو برای: azgh 102
تعداد نتایج: 24427 فیلتر نتایج به سال:
An abstract is not available for this content so a preview has been provided. As you have access to content, full PDF via the ‘Save PDF’ action button.
پایان نام? پیش رو با عنوان "اعراب و بلاغت نهج البلاغه (خطبه 94 تا 102)" ضمن تحلیل خطبه های مورد نظر برای دستیابی به این مهم ابتدا به بررسی خطب از نظر اعرابی پرداخته که حاصل آن در قالب اعراب مفردات و اعراب جمل در فصل دوم ارائه شده است و سپس خطبه های مورد نظر را از نقطه نظر بلاغی در سه حوز? معانی، بیان و بدیع واکاوی نموده و نکات شاخص و اختلاف نظرهای هردوبخش را در فصلی جداگانه ارائه نموده است. ...
An abstract is not available for this content so a preview has been provided. As you have access to content, full PDF via the ‘Save PDF’ action button.
MBX-102/JNJ-39659100 (MBX-102) is a selective, partial PPAR-γ agonist that lowers glucose in the absence of some of the side effects, such as weight gain and edema, that are observed with the TZDs. Interestingly MBX-102 also displays pronounced triglyceride lowering in preclinical rodent models and in humans. Although in vitro reporter gene studies indicated that MBX-102 acid is a highly select...
Background and purpose: Bioindicators are microorganisms directly associated with environmental changes which their numbers are affected by chemical pollutants. Materials and methods: Sampling was done from four stations in Shirood River in depth of 20 cm of water surface and transferred to laboratory in less than 24 hr. KF medium, SPS, ECC Chrome agar, Plate count agar were used for isolati...
Two once-a-month preparations cyclo provera (Depo-medroxy Progesterone Acetate 25 mg and Estradiol Cypionate 5 mg) and HRP-102 (Norethisterone enanthate 50 mg and Estradiol Valerate 5 mg) were tried in two groups of women by random allocation, and their effectiveness, complaints and reasons for discontinuation were studied. A total of 206 women were admitted (104 on cyclo provera and 102 on HRP...
Jennie Johnstone, MD; Mark Loeb, MD, MSc; Koon K. Teo, MBBCh, PhD; Peggy Gao, MSc; Leanne Dyal, MSc; Lisheng Liu, MD; Alvaro Avezum, MD, PhD; Ernesto Cardona-Munoz, MD; Peter Sleight, MD; Robert Fagard, MD, PhD; Salim Yusuf, MD, DPhil; on behalf of the Ongoing Telmisartan Alone and in Combination With Ramipril Global EndPoint Trial (ONTARGET) and Telmisartan Randomized Assessment Study in ACE I...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید